Accession Number: | 0001209191-18-025141 |
Date: | 2018-04-17 |
Issuer: | INSYS THERAPEUTICS, INC. (INSY) |
Original Submission Date: |
MOTAHARI SAEED
C/O INSYS THERAPEUTICS, INC.
1333 SOUTH SPECTRUM BLVD, SUITE 100
CHANDLER, AZ 85286
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2018-04-17 | A | 11,000 | a | $0.00 | 26,400 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2018-04-17 | deemed execution date | D | 11,000 (d) | common stock 11,000 | $0.00 | 22,000 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
f2 | on april 17, 2017, the reporting person received a 33,000 share restricted stock unit award ("rsus"). the rsus vest in 3 equal annual installments beginning on april 17, 2018 and will be fully vested on april 17, 2020, in all cases so long as there has been no break in the reporting person's continuous service through such date. |